NCT05629845 Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients Status RECRUITING Phase NA
NCT05627297 Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image Status RECRUITING Phase N/A
NCT05626985 Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT05625893 Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion Status COMPLETED Phase PHASE2
NCT05623150 CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome Status RECRUITING Phase N/A
NCT05622136 Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05621499 HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT05620771 Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk Status RECRUITING Phase PHASE2
NCT05620134 Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05617430 Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT05616390 Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT05613621 Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05613478 Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma Status RECRUITING Phase PHASE3
NCT05612477 Blood Salvage in Orthotopic Liver Transplantation With HCC Status ACTIVE_NOT_RECRUITING Phase NA
NCT05603572 KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) Status SUSPENDED Phase PHASE1/PHASE2
NCT05602974 Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study Status NOT_YET_RECRUITING Phase NA
NCT05595473 A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05594927 Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) Status RECRUITING Phase PHASE3
NCT05582018 Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures Status TERMINATED Phase NA